<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03720665</url>
  </required_header>
  <id_info>
    <org_study_id>UMCGoettingen</org_study_id>
    <nct_id>NCT03720665</nct_id>
  </id_info>
  <brief_title>Cortical Excitability Changes on the Sensorimotor Cortex Induced by Caffeine Consumption: A TMS Study</brief_title>
  <official_title>Cortical Excitability Changes on the Sensorimotor Cortex Induced by Caffeine Consumption: A TMS Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Center Goettingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Medical Center Goettingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Caffeine is a widely used psychostimulant drug and acts as a competitive antagonist at
      adenosine receptors. Its effect is on neurons and glial cells of all brain areas. Chronic
      consumption of caffeine leads to tolerance which might be associated with an increased number
      of binding sites in the brain. In deep brain stimulation (DBS), the production of adenosine
      following the release of adenosine triphosphate (ATP) explains the reduction of in tremor.
      Binding of adenosine to adenosine A1 receptor suppresses excitatory transmission in the
      thalamus and thus reduces both tremor-and DBS-induced side effects. Also, the effect of
      adenosine was attenuated following the administration of the
      8-Cyclopentyl-1,3-dipropylxanthine (DPCPX) adenosine A1 receptor antagonist. Therefore, the
      presence of a receptor antagonist such as caffeine was suggested to reduce the effectiveness
      of deep brain stimulation (DBS) in treating tremor and other movement disorders.

      In light with this finding, we anticipate that the antagonistic effect of caffeine is a
      culprit to the reduction of effectiveness of any stimulation protocol in non-invasive
      stimulation (NIBS). In particular the excitatory effects of a NIBS protocol can tentatively
      be blocked in the presence of caffeine.

      In this study, the effects of caffeine consumption on cortical excitability at the
      sensorimotor cortex shall be examined on focal and non-focal plasticity. Focal plasticity
      will be induced by paired associated stimulation (PAS) and global cortical plasticity from
      transcranial alternating current (tACS) stimulation. In case of tACS stimulation, 1) an
      excitatory protocol (tACS, 140 Hz, 1 mA) and 2) an inhibitory protocol (tACS, 140 Hz, 0.4 mA)
      with the active electrode over M1 and the return electrode over the orbitofrontal cortex will
      be used. Changes in cortical excitability are assessed using transcranial magnetic
      stimulation (TMS) recordings.

      Research goals are to examine the effects of caffeine consumption on sensorimotor cortical
      excitability and stimulation induced plasticity. In addition, this study explores further
      factors which usually contribute to variability in cortical excitability studies. The results
      are expected to give a useful recommendation for researchers to reduce confounding factors
      and hereby improves repeatability.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 1, 2018</start_date>
  <completion_date type="Actual">November 18, 2019</completion_date>
  <primary_completion_date type="Actual">November 18, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>15 participants are assigned to caffeine group and another 15 are assigned to placebo group. Then, the participants who were initially in the caffeine group now be in placebo group and those who were in the placebo group were assigned to caffeine group. Finally, all participants received both placebo and caffeine</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>A statistician prepares a randomization list. Only pharmacist knows the medication type (caffeine or placebo) and the type of electrical stimulation. An investigator is blinded to the type of electrical stimulation and medication. In addition, all participants are naive to electrical stimulation and does not know type of medications that they receive</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Cortical excitabiliy changes induced by caffeine consumption</measure>
    <time_frame>Baseline (pre-measurement), immediately after intervention, 5 minutes, 10 minutes, 15 minutes, 20 minutes, 25 minutes, 30 minutes, 60 minutes</time_frame>
    <description>Amplitude of motor evoked potential change (MEP)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Brain-derived neurotrophic factor (BDNF) gene polymorphisms on cortical plasticity</measure>
    <time_frame>3-6 months</time_frame>
    <description>Valine (Val) and Methionine (Met) alleles (i.e. Val66Met; Val66Val; Met66Met; Met66Val)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">30</enrollment>
  <condition>Cortical Excitability</condition>
  <condition>Brain Stimulation</condition>
  <arm_group>
    <arm_group_label>Caffeine group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>200mg caffeine tablet
transcranial alternating current stimulation (140 Hz tACS) at 1 mA
transcranial alternating current stimulation (140 Hz tACS) at 0.4 mA
transcranial alternating current stimulation (140 Hz tACS) sham
paired associative stimulation (PAS 25)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Non-active tablet
transcranial alternating current stimulation (140 Hz tACS) at 1 mA
transcranial alternating current stimulation (140 Hz tACS) at 0.4 mA
transcranial alternating current stimulation (140 Hz tACS) sham
paired associative stimulation (PAS 25)</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Caffeine_TMS</intervention_name>
    <description>Caffeine group: participants will receive a caffeine tablet and all electrical stimulations in a random order [transcranial electrical stimulation (tACS 140 Hz at 1 mA, 0.4 mA, sham) and paired associative stimulation (PAS 25)] Placebo tablet: participants will receive a placebo tablet and all electrical stimulations in a random order [transcranial electrical stimulation (tACS 140 Hz at 1 mA, 0.4 mA, sham) and paired associative stimulation (PAS 25)]</description>
    <arm_group_label>Caffeine group</arm_group_label>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and female healthy participants between the ages of 18-45.

          -  Right-handed (Oldfield 1971).

          -  Free willing participation and written, informed consent of all subjects obtained
             prior to the start of the study.

          -  Participant who willingly stop consuming caffeinated drinks at least three days before
             the experiment is performed

          -  Participant's weight is above 60 kg

        Exclusion Criteria:

          -  Age &lt; 18 or &gt; 45 years old;

          -  Left hand dominant;

          -  Evidence of a chronic disease or residuals of a disorder of the nervous system in the
             history, in particular

          -  stroke

          -  History of epileptic seizures;

          -  Pacemaker or deep brain stimulation;

          -  Metal implants in the head region (metal used in the head region, for example, clips
             after the operation of an intracerebral aneurysm (vessel sacking in the region of the
             brain vessels), implantation of an artificial auditory canal);

          -  Cerebral trauma with loss of consciousness in prehistory;

          -  Existence of a serious internal (internal organs) or psychiatric (mental illness)

          -  Alcohol, medication or drug addiction;

          -  Receptive or global aphasia (disturbance of speech comprehension or additionally of
             speech);

          -  Participation in another scientific or clinical study within the last 4 weeks;

          -  Pregnancy

          -  Still period

          -  Participant who is unable to tolerate with caffeine or coffee products

          -  Participant who has abnormal heart activity from an electrocardiography (ECG) finding

          -  Weight is less than 60 kg
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Walter Paulus, Prof. Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Goettingen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Prof. Dr. Walter Paulus</name>
      <address>
        <city>Goettigen</city>
        <state>Lower Saxony</state>
        <zip>37075</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Oldfield RC. The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia. 1971 Mar;9(1):97-113.</citation>
    <PMID>5146491</PMID>
  </reference>
  <reference>
    <citation>Antal A, Alekseichuk I, Bikson M, Brockmöller J, Brunoni AR, Chen R, Cohen LG, Dowthwaite G, Ellrich J, Flöel A, Fregni F, George MS, Hamilton R, Haueisen J, Herrmann CS, Hummel FC, Lefaucheur JP, Liebetanz D, Loo CK, McCaig CD, Miniussi C, Miranda PC, Moliadze V, Nitsche MA, Nowak R, Padberg F, Pascual-Leone A, Poppendieck W, Priori A, Rossi S, Rossini PM, Rothwell J, Rueger MA, Ruffini G, Schellhorn K, Siebner HR, Ugawa Y, Wexler A, Ziemann U, Hallett M, Paulus W. Low intensity transcranial electric stimulation: Safety, ethical, legal regulatory and application guidelines. Clin Neurophysiol. 2017 Sep;128(9):1774-1809. doi: 10.1016/j.clinph.2017.06.001. Epub 2017 Jun 19. Review.</citation>
    <PMID>28709880</PMID>
  </reference>
  <reference>
    <citation>Bekar L, Libionka W, Tian GF, Xu Q, Torres A, Wang X, Lovatt D, Williams E, Takano T, Schnermann J, Bakos R, Nedergaard M. Adenosine is crucial for deep brain stimulation-mediated attenuation of tremor. Nat Med. 2008 Jan;14(1):75-80. Epub 2007 Dec 23.</citation>
    <PMID>18157140</PMID>
  </reference>
  <reference>
    <citation>Cappelletti S, Piacentino D, Sani G, Aromatario M. Caffeine: cognitive and physical performance enhancer or psychoactive drug? Curr Neuropharmacol. 2015 Jan;13(1):71-88. doi: 10.2174/1570159X13666141210215655. Review. Erratum in: Curr Neuropharmacol. 2015;13(4):554. Daria, Piacentino [corrected to Piacentino, Daria].</citation>
    <PMID>26074744</PMID>
  </reference>
  <reference>
    <citation>Cappelletti S, Piacentino D, Fineschi V, Frati P, Cipolloni L, Aromatario M. Caffeine-Related Deaths: Manner of Deaths and Categories at Risk. Nutrients. 2018 May 14;10(5). pii: E611. doi: 10.3390/nu10050611. Review.</citation>
    <PMID>29757951</PMID>
  </reference>
  <reference>
    <citation>Feurra M, Paulus W, Walsh V, Kanai R. Frequency specific modulation of human somatosensory cortex. Front Psychol. 2011 Feb 2;2:13. doi: 10.3389/fpsyg.2011.00013. eCollection 2011.</citation>
    <PMID>21713181</PMID>
  </reference>
  <reference>
    <citation>Higdon JV, Frei B. Coffee and health: a review of recent human research. Crit Rev Food Sci Nutr. 2006;46(2):101-23. Review.</citation>
    <PMID>16507475</PMID>
  </reference>
  <reference>
    <citation>Márquez-Ruiz J, Leal-Campanario R, Sánchez-Campusano R, Molaee-Ardekani B, Wendling F, Miranda PC, Ruffini G, Gruart A, Delgado-García JM. Transcranial direct-current stimulation modulates synaptic mechanisms involved in associative learning in behaving rabbits. Proc Natl Acad Sci U S A. 2012 Apr 24;109(17):6710-5. doi: 10.1073/pnas.1121147109. Epub 2012 Apr 9.</citation>
    <PMID>22493252</PMID>
  </reference>
  <reference>
    <citation>Moliadze V, Antal A, Paulus W. Boosting brain excitability by transcranial high frequency stimulation in the ripple range. J Physiol. 2010 Dec 15;588(Pt 24):4891-904. doi: 10.1113/jphysiol.2010.196998.</citation>
    <PMID>20962008</PMID>
  </reference>
  <reference>
    <citation>Moliadze V, Antal A, Paulus W. Electrode-distance dependent after-effects of transcranial direct and random noise stimulation with extracephalic reference electrodes. Clin Neurophysiol. 2010 Dec;121(12):2165-71. doi: 10.1016/j.clinph.2010.04.033. Epub 2010 Jun 15.</citation>
    <PMID>20554472</PMID>
  </reference>
  <reference>
    <citation>Moliadze V, Atalay D, Antal A, Paulus W. Close to threshold transcranial electrical stimulation preferentially activates inhibitory networks before switching to excitation with higher intensities. Brain Stimul. 2012 Oct;5(4):505-11. doi: 10.1016/j.brs.2011.11.004. Epub 2012 Feb 22.</citation>
    <PMID>22445135</PMID>
  </reference>
  <reference>
    <citation>Nitsche MA, Paulus W. Excitability changes induced in the human motor cortex by weak transcranial direct current stimulation. J Physiol. 2000 Sep 15;527 Pt 3:633-9.</citation>
    <PMID>10990547</PMID>
  </reference>
  <reference>
    <citation>Polanía R, Nitsche MA, Korman C, Batsikadze G, Paulus W. The importance of timing in segregated theta phase-coupling for cognitive performance. Curr Biol. 2012 Jul 24;22(14):1314-8. doi: 10.1016/j.cub.2012.05.021. Epub 2012 Jun 7.</citation>
    <PMID>22683259</PMID>
  </reference>
  <reference>
    <citation>Stefan K, Kunesch E, Cohen LG, Benecke R, Classen J. Induction of plasticity in the human motor cortex by paired associative stimulation. Brain. 2000 Mar;123 Pt 3:572-84.</citation>
    <PMID>10686179</PMID>
  </reference>
  <reference>
    <citation>Stefan K, Kunesch E, Benecke R, Cohen LG, Classen J. Mechanisms of enhancement of human motor cortex excitability induced by interventional paired associative stimulation. J Physiol. 2002 Sep 1;543(Pt 2):699-708.</citation>
    <PMID>12205201</PMID>
  </reference>
  <reference>
    <citation>Zaehle T, Rach S, Herrmann CS. Transcranial alternating current stimulation enhances individual alpha activity in human EEG. PLoS One. 2010 Nov 1;5(11):e13766. doi: 10.1371/journal.pone.0013766.</citation>
    <PMID>21072168</PMID>
  </reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>October 24, 2018</study_first_submitted>
  <study_first_submitted_qc>October 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 25, 2018</study_first_posted>
  <last_update_submitted>November 27, 2019</last_update_submitted>
  <last_update_submitted_qc>November 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 29, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Center Goettingen</investigator_affiliation>
    <investigator_full_name>Prof. Dr. Walter Paulus</investigator_full_name>
    <investigator_title>Prof. Dr.</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Caffeine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

